Control of early aspergillus mortality after lung transplantation: Outcome and risk factors

Transplantation Proceedings

Volumn 42, Issue 10, 2010, Pages 4459-4464

  Eriksson, M ^a   Lemstrom K ^a   Suojaranta Ylinen, R ^a   Martelius, T ^a   Harjula, A ^a   Sipponen, J ^a   Halme, M ^a   Piilonen, A ^a   Salmenkivi, K ^b   Anttila, V J ^a   Hammainen P ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; AZATHIOPRINE; CASPOFUNGIN; CEFTAZIDIME; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; IMMUNOSUPPRESSIVE AGENT; MEROPENEM; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTAMIDINE; TACROLIMUS; VALGANCICLOVIR; VORICONAZOLE;

ADD ON THERAPY; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ASPERGILLOMA; ASPERGILLOSIS; ASPERGILLUS; BRONCHIOLITIS OBLITERANS; CANDIDEMIA; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DEATH; DRUG WITHDRAWAL; EMPHYSEMA; FEMALE; FIBROSIS; FOLLOW UP; FUNGAL COLONIZATION; HEMOPTYSIS; HIGH RISK PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MYCOSIS; OUTCOME ASSESSMENT; PNEUMOCYSTIS JIROVECI; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROPHYLAXIS; PULMONARY VENO-OCCLUSIVE DISEASE; RISK FACTOR; SIDE EFFECT; UNSPECIFIED SIDE EFFECT;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; ASPERGILLOSIS; FOLLOW-UP STUDIES; HUMANS; LUNG TRANSPLANTATION; RISK FACTORS;

EID: 78650458056     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.09.116     Document Type: Conference Paper

References (27)

1. N. Singh, and S. Husain Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management J Heart Lung Transplant 22 2003 258
2. B.C. Cahill, J.R. Hibbs, and K. Savik Aspergillus airway colonisation and invasive disease after lung transplantation Chest 112 1997 1160
3. S.M. Gordon, and R.K. Avery Aspergillosis in lung transplantation; incidence, risk factors and prophylactic strategies Transpl Infect Dis 3 2001 161
4. M. Iversen, C.M. Burton, and S. Vand Aspergillus infection in lung transplant patients: incidence and prognosis Eur J Clin Microbiol Infect Dis 26 2007 879
5. S. Husein, D. Zaldonis, and S. Kusne Variation in antifungal prophylaxis strategies in lung transplantation Transpl Infect Dis 8 2006 213
6. E. Marini, and J.C. Gallagher Prophylactic antifungal agents used after lung transplantation Ann Pharmacother 44 2010 546
7. S. Husein, D.L. Paterson, and S. Studer Voriconazole prophylaxis in lung transplant recipients Am Transplant 6 2006 3008
8. S.M. Hosseini-Moghaddam, and S. Husein Fungi and molds following lung transplantation Semin Respir Crit Care Med 31 2010 222
9. V. Monforte, A. Roman, and J. Gavalda Nebulized amphotericin B prophylaxis for Aspergillus infection in lung transplantation; study of risk factors J Heart Lung Transplant 20 2001 1274
10. R.H. Drew, E.D. Ashley, and D.K. Benjamin Jr Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung transplant recipients Transplantation 77 2004 232
11. E.J. Ruijgrok Inhalation of amphotericin B formulations for prevention and treatment of invasive pulmonary aspergillosis Thesis 2002 Erasmus Universiteit Rotterdam, The Netherlands
12. V. Monforte, P. Ussetti, and J. Gavalda Feasibility, tolerability, and outcomes of nebulized liposomal amphotericin B for Aspergillus infection prevention in lung transplantation J Heart Lung Transplant 29 2010 523
13. S.M. Palmer, R.H. Drew, and J.D. Whitehouse Safety of aerosolized amphotericin B lipid complex in lung transplant recipients Transplantation 72 2001 545
14. J.M. Borro, A. Sole, and M. de la Torre Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation Transplant Proc 40 2008 3090
15. B. de Pauw, T.J. Walsh, and J.P. Donnelly Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Disease Mycoses Study Group (EORTC/MSG) Consensus Group Clin Infect Dis 46 2008 1813
16. A. Sole, P. Morant, and M. Salavert Aspergillus infections in lung transplant recipients: risk factors and outcome Clin Microbiol Infect 11 2005 359
17. M.L. Plit, L.G. Singleton, and A. Scot Is invasive fungal disease in lung transplant recipients predictable? J Heart Lung Transplant 22 2003 A367
18. B. Mehrad, G. Paciocco, and F.J. Martinez Spectrum of Aspergillus infection in lung transplant recipients: case series and review of literature Chest 119 2001 169
19. M. Helmi, R.B. Love, and D. Welter Aspergillus infections in transplant recipients with cystic fibrosis: risk factors and outcomes in comparison to other types of transplant recipients Chest 123 2003 800
20. L.J. Paradowski Saprophytic fungal infections and lung transplantation: revisited J Heart Lung Transplant 16 1997 524
21. D. Hadjiliadis, T.A. Sporn, and J.R. Perfect Outcome of lung transplantation in patients with mycetomas Chest 121 2002 128
22. A. Vadnerkar, J.C. Cornelius, and U. Celik Impact of mold infections in explanted lungs on outcomes of lung transplantation Transplantation 2 2010 27
23. J.S. Dummer, N. Lazariashvili, and J. Barnes A survey of antifungal management in lung transplantation J Heart Lung Transplant 23 2004 1376
24. E.J. Ruijgrok, M.H. Fens, and I.A. Bakker-Woudenberg Nebulization of four commercially available amphotericin B formulations in persistently granulocytopenic rats with invasive pulmonary aspergillosis: evidence for long term biological activity J Pharm Pharmacol 57 2005 1289
25. C. Gutierrez, S. Al-Faifi, and C. Chaparro The effect of recipient's age on transplantation outcome Am J Transplant 7 2007 1271
26. D. Hadjiliadis, D.N. Howell, and R.D. Davis Anastomotic infections in lung transplant recipients Ann Transplant 5 2000 13
27. D.R. Nunley, A.A. Gal, and J.D. Vega Saprophytic fungal infections and complications involving the bronchial anastomosis following human lung transplantation Chest 122 2002 1185